Table 2.
Arm | |||||
---|---|---|---|---|---|
Characteristic | A | B | C | D | Total |
Number of patients | 38 | 40 | 38 | 53 | 167 |
Age, years | |||||
Median | 62 | 61 | 61 | 58 | 61 |
Range | (26–83) | (44–84) | (35–78) | (37–83) | (26–84) |
Sex, % | |||||
Male | 58 | 75 | 74 | 66 | 69 |
Female | 42 | 25 | 26 | 34 | 31 |
AJCC Stage, % | |||||
M1a | 2 | 5 | 0 | 0 | 2 |
M1b | 8 | 18 | 3 | 0 | 6 |
M1c | 90 | 77 | 97 | 100 | 92 |
EECOG PS, % | |||||
PS 0 | 71 | 90 | 50 | 72 | 75 |
PS1 | 29 | 10 | 50* | 28 | 25 |
No. prior therapies, median | 0 | 0 | 1 | 0 | 0 |
Prior chemotherapy, % | 11 | 10 | 100 | 19 | 37 |
LDH, % | |||||
<ULN | 61 | 58 | 36 | 47 | 51 |
ULN < LDH <2XULN | 23 | 23 | 42 | 36 | 31 |
>2XULN | 16 | 19 | 22 | 17 | 18 |
p <0.05 compared to Arms A, B, D. Abbreviations: AJCC, American Joint Committee on Cancer; ECOG, Eastern Cooperative Group; PS Performance Status; ULN, Upper Limit of Normal